Last reviewed · How we verify
NCT05529563
The Effect of Laparoscopic Sleeve Gastrectomy on Insulin Secretion Pattern in Morbidly Obese Patients With Acanthosis Nigricans
trial testing LSG in Morbid Obesity in 138 participants. Status unknown.
1 October 2022
Quick facts
| Lead sponsor | Shen Qu |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 138 |
| Start date | 1 June 2017 |
| Primary completion | 1 October 2022 |
| Estimated completion | 31 October 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- LSG
Conditions studied
- Morbid Obesity — all drugs for Morbid Obesity →
- Acanthosis Nigricans — all drugs for Acanthosis Nigricans →
- Insulin Resistance — all drugs for Insulin Resistance →
- Insulin Sensitivity — all drugs for Insulin Sensitivity →
Sponsor
Shen Qu
Who can join
Adults 18 to 65, any sex, with Morbid Obesity or Acanthosis Nigricans. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acanthosis nigricans (AN) is increasing in its prevalence and is the most prevalent cutaneous manifestation in individuals with obesity. Insulin resistance or hyperinsulinemia is the main pathophysiological mechanism of obesity-related AN. However, the effect of laparoscopic sleeve gastrectomy (LSG) on insulin secretion pattern in Chinese morbidly obese patients with AN is unknown. In these study, the investigators aimed to explore the insulin secretion patterns in Chinese morbidly obese patients with Acanthosis nigricans (AN) and their alterations after LSG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05529563
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of LSG
Trials testing the same drug.
- NCT05603338 — Naturally Banded Sleeve Gastrectomy · NA · completed
- NCT04287972 — A Study to Reduce the Reflux After a Sleeve Gastrectomy in Obese Patients · NA · withdrawn
- NCT03821688 — SAS-J Compared to OAGB and LSG as a Treatment for Morbid Obesity · NA · completed
- NCT05166954 — Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension · recruiting
- NCT04573998 — Study on the Mechanism of lcn2 in Obesity · unknown
Other recruiting trials for Morbid Obesity
Currently open trials in the same condition.
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
- NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
- NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
- NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
- NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting
Other Shen Qu trials
Trials by the same sponsor.
- NCT05528393 — Prolactin and FGF21 in Gestational Diabetes Mellitus · unknown
- NCT05525884 — Mechanism of Serum PRL in the Development of MAFLD · unknown
- NCT04573998 — Study on the Mechanism of lcn2 in Obesity · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05529563 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shen Qu
- Last refreshed: 7 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05529563.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing